Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Cannabinoid Science Podcasts

show episodes
 
Artwork

1
PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast

PVI, PeerView Institute for Medical Education

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
  continue reading
 
Artwork

1
The Dime

Bryan Fields & Kellan Finney

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
The $100+ billion cannabis industry is fueled by innovative strategies and visionary leaders. Each week, we explore the journeys of CEOs from publicly traded giants, world-renowned scientists, and underground legacy growers shaping the future of this transformative market. Bryan and Kellan uncover how these pioneers built their businesses, navigated failures and found success in this rapidly growing space. Join us to explore the lessons and insights driving the cannabis industry forward.
  continue reading
 
Artwork
 
In Cannabis Voices, Mary Biles - medical cannabis writer and author of ‘The CBD Book – The Essential Guide to CBD oil’ - speaks to patients, carers, cannabinoid scientists, doctors and activists about the healing power of the cannabis plant.
  continue reading
 
Artwork

1
PeerView Neuroscience & Psychiatry CME/CNE/CPE Video Podcast

PVI, PeerView Institute for Medical Education

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
  continue reading
 
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
  continue reading
 
Artwork

1
CannaCAST IL

Heli Dangur, Narkis Tessler

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
CannaCAST IL was formed to strengthen and empower the Medical Cannabis industry by providing international exposure to Israel’s technology, R&D and innovation.
  continue reading
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The B ...
  continue reading
 
Periodic Effects focuses on the science and business of cannabis. Wayne Schwind, the CEO & Founder of Periodic Edibles, hosts the show. With his background in Chemical Engineering, Wayne dives deep with future leaders inside the cannabis industry. Educational insights on cannabinoids, terpenes, endo-cannabinoid system, extraction methods, edibles and growing science.
  continue reading
 
This show is for educational purposes and should not be taken as medical advice, Dr. O is a clinical pharmacist certified in medical cannabis. In this podcast, you will learn about alternative ways to improve your health and well-being using the healing power of medicinal herbs such as cannabinoids, psychedelics, and conventional therapy.
  continue reading
 
Artwork

1
Shaping Fire

Shango Los

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Shaping Fire host Shango Los interviews the most knowledgable and insightful people in cannabis and entheogens. With topics ranging from cannabis cultivation, medicine and hashmaking, to healing humans with psychedelics.
  continue reading
 
Artwork

1
The Higher Estate

The Higher Estate with Dr Ira Price

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Hosted by Dr.Ira price, The Higher Estate is building community through education. We aim to bridge the gap between medical and recreational cannabis through conversation and information. Dr. Price opened a FREE medical clinic in cannabinoid medicine in 2011 in Hamilton, Ontario and frequently educates other physicians on the topic, and is available to the media for interviews and commentary on cannabis medicine and related issues.
  continue reading
 
Artwork

1
Learn Real Good

Learn Real Good

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Learn Real Good is a podcast that brings science to the masses by combining comedy and cutting-edge science. We create a friendly and casual atmosphere to discuss STEM research with grad students. We want to peel back the curtain on how science is done and what it means to be a scientist while improving scientific literacy in the general public. We also want our audience to laugh their butts off.
  continue reading
 
Jamie Corroon, ND, MPH is the founder and Medical Director of the Center for Medical Cannabis Education. Dr. Corroon is a licensed Naturopathic Doctor and clinical researcher. In addition, Dr. Corroon advises dietary supplement and cannabis companies regarding science, regulation, and product development. Dr. Corroon is well published in the peer-review literature, with recent publications that investigate the clinical and public health implications of the broadening acceptance of Cannabis i ...
  continue reading
 
Artwork

1
Beyond Buds

People's California

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
From People's comes Beyond Buds, where we go far out to find new stories about your favorite plant. Experts and activists from the whole spectrum of the cannabis industry are here to chat. Why don't you step on in, bud?
  continue reading
 
Loading …
show series
 
Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use. Kevin Hill, MD, MHS, of Harvard Medical School joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about the therapeutic use of cannabis and cannabinoids in adults, potential harms, and evidenc…
  continue reading
 
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Andrew Menzies-Gow, MBBS, PhD, Vice President Respiratory & Immunology, Global Biopharmaceuticals Medical, AstraZeneca, about innovations in respiratory and immunology drug development. Dr. Menzies-Gow is an expert in …
  continue reading
 
We love to hear from our listeners. Send us a message. On this week's episode, Cyril Konto, M.D., president, executive director, and CEO at Ichnos Glenmark Innovation (IGI) talks about the promise of multi-specific antibodies, funding the company during the 'biotech winter,' closing a $700 million upfront licensing deal with AbbVie, the impact of C…
  continue reading
 
Everyone in cannabis talks about effects-based products — almost no one can deliver them consistently. Repeatable experiences require precision and formulation discipline that looks a lot more like pharma than cannabis. And here’s why: most operators don’t treat in-house analytics as essential. But that’s the mistake. Process control isn’t optional…
  continue reading
 
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Peter Vanderklish, PhD, chief scientific officer at Spinogenix, a company developing therapeutics aimed at restoring synaptic connections for conditions such as ALS, Alzheimer’s disease, schizophrenia and Fragile X syn…
  continue reading
 
Peripheral neuropathy affects approximately 1% of adults worldwide and can be associated with significant disability. Author Michelle Mauermann, MD, of the Mayo Clinic in Minnesota joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss diagnosis and optimal management of peripheral neuropathy. Related Content: Peripheral Neuropathy…
  continue reading
 
We love to hear from our listeners. Send us a message. Allan Shaw, Chief Financial Officer and Chief Business Officer at Create Medicines, is back on the Business of Biotech this week, with a temperature check on biotech funding and the IPO market. We discuss the implications of recent blockbuster acquisitions, strategies for managing the current f…
  continue reading
 
Tobacco and alcohol are already laying the groundwork for cannabis — building IP, infrastructure, and data. Nick Kenney breaks down what legacy industries already understand — how regulated markets are built, and why readiness always beats speed. This week we sit down with Nick Kenny to discuss: • How tobacco and alcohol are entering cannabis • The…
  continue reading
 
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/APF865. …
  continue reading
 
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/CXV865. CME/AAPA c…
  continue reading
 
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/APA/IPCE information, and to apply for credit, please visit us at PeerView.…
  continue reading
 
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/APF865. …
  continue reading
 
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/CXV865. CME/AAPA c…
  continue reading
 
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/APA/IPCE information, and to apply for credit, please visit us at PeerView.…
  continue reading
 
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Pol Boudes, MD, Chief Medical Officer at Rectify Pharma. Rectify Pharma is a biotechnology company pioneering a positive functional modulators (PFM) platform to address the root causes of genetic and protein folding di…
  continue reading
 
Metabolic dysfunction-associated steatotic liver disease (MASLD), an increasingly prevalent condition among adults worldwide, is associated with liver-related complications, hepatocellular carcinoma, and certain extrahepatic cancers. Author Norbert Stefan, MD, from the University Hospital of Tübingen in Tübingen, Germany, discusses this and more wi…
  continue reading
 
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Mardi Dier, CFO at Madrigal Pharmaceuticals, talks about building relationships in investment banking and investor relations before moving into business development and becoming a chief financial officer. Mardi describes how drug companies tran…
  continue reading
 
Before Target and DoorDash, Edible Arrangements joined the cannabinoid space. Supply chains look a lot different when you can lean on national infrastructure, logistics, and distribution that already exist. Through Edibles.com, the company is using that foundation to build access — curating top brands and letting customers shop the way they underst…
  continue reading
 
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Mike Denne, PharmD, Vice President of US Medical Affairs for Rare Disease and Plasma Derived Therapies at Takeda, to discuss the company’s approach to advancing patient care in the area of rare diseases through medical…
  continue reading
 
The JAMA Summit on Firearm Violence convened 60 thought leaders from a wide array of disciplines to chart a roadmap that could lead to substantial reductions in firearm harms by 2040. Frederick P. Rivara, MD, MPH, of the University of Washington joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the Summit and steps that c…
  continue reading
 
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Bernard Ravina, M.D., CEO at Vima Therapeutics, a company that emerged from stealth in May with $60 million Series A financing to develop an oral candidate for dystonia, a movement disorder. Ravina talks about transitioning …
  continue reading
 
Keratinocyte carcinomas, which include basal cell carcinoma and squamous cell carcinoma, are common forms of skin cancer. Approximately 5.4 million keratinocyte carcinomas are diagnosed in the US annually. Author Mackenzie R. Wehner, MD, MPhil, of the University of Texas MD Anderson Cancer Center joins JAMA Associate Editor David Simel, MD, MHS, to…
  continue reading
 
What happens when years of iteration, engineering, and a unique understanding of the plant align? In cannabis, building hardware is walking a tightrope — precision, timing, and vision all matter. Singular, the latest release from Active710, connects that entire loop. While most will gravitate toward its sleek, modular design, the real story lies in…
  continue reading
 
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, welcomes Mike Exton, PhD, CEO of Lexicon Pharmaceuticals, for a conversation about leveraging gene science to develop innovative medicines for serious chronic conditions. Dr. Exton discusses Lexicon’s growing pipeline, which …
  continue reading
 
We love to hear from our listeners. Send us a message. On this week's episode — the last of our four-part series focused on South Florida — we catch up with Rich Daly, CEO at Catalyst Pharmaceuticals, a member of Life Science Leader's editorial advisory board and Miami-based location host for our in-person series. Rich talks about Catalyst's rare d…
  continue reading
 
What happens when a Silicon Valley exec who helped Lyft rewrite the rules brings that same playbook to cannabis? This week we sit down with Ashwin Raj, CEO of LeafLink, to break down how disciplined tech thinking and first-principle strategy can reshape a fragmented industry. In this episode: • How Lyft’s regulatory battles mirror cannabis today • …
  continue reading
 
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, spoke with R. Nolan Townsend, MBA, CEO of Lexeo Therapeutics, a company developing gene therapies for cardiovascular diseases as well as CNS disorders including Alzheimer’s disease. Lexeo recently announced a partnership to a…
  continue reading
 
Lung cancer in nonsmoking individuals is increasing worldwide and currently accounts for 15% to 20% of lung cancer cases globally. Benjamin Solomon, PhD, of the Peter MacCallum Cancer Centre in Melbourne, Australia, discusses the epidemiology and treatment of lung cancer in nonsmoking patients with JAMA Deputy Editor Kristin Walter, MD, MS. Related…
  continue reading
 
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech -- part three in a four part series recorded in-person at Catalyst Pharmaceuticals' Miami headquarters -- Anthony Japour, M.D., CEO at iTolerance, talks about his work as a physician treating infectious diseases, his CEO role in diagnostics at t…
  continue reading
 
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD c…
  continue reading
 
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD c…
  continue reading
 
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/AJT865. CME credit will…
  continue reading
 
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/AJT865. CME credit will…
  continue reading
 
Syphilis infections have increased in the US and worldwide over the past decade. Left untreated, syphilis can cause blindness, deafness, psychosis, dementia, and peripheral nerve damage, and can cause congenital syphilis. Author Franco Chevalier, MD, MPH, from the San Francisco Department of Public Health discusses this and more with JAMA Deputy Ed…
  continue reading
 
Setbacks early on can reshape everything. They can alter your future strategy, shift your appetite for risk, and — if you’re patient — quietly set you up for success while others chase growth at any cost. As with any company, “figuring it out” is part of the job. And sometimes, that figuring it out happens faster than you’d ever hope. The challenge…
  continue reading
 
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, spoke with Juan Domínguez-Bendala, PhD, Director of Stem Cell and Pancreatic Regeneration Programs, Diabetes Research Institute (DRI) at the University of Miami, to discuss his research team’s new research published in Nature…
  continue reading
 
Microplastics, defined as plastics smaller than 5 mm, have been detected in human tissues at increasing rates and are associated with potential adverse health effects. Author David Christiani, MD, MPH, from the Department of Environmental Health at Harvard T.H. Chan School of Public Health, discusses this topic and more with JAMA Deputy Editor Kris…
  continue reading
 
We love to hear from our listeners. Send us a message. In this week's episode of the Business of Biotech -- part two in a four-part series recorded in-person at Catalyst Pharmaceuticals' Miami headquarters -- we're speaking with Daniel Teper, an entrepreneur and most recently, founder and CEO at NAYA Therapeutics. Based in South Florida, NAYA is de…
  continue reading
 
Building something that lasts takes more than money — it takes self-belief, grit, and the willingness to keep pushing forward when easier options present themselves. Putting your name on it only adds to the weight — and the responsibility — to make it work. As with anything worth doing, there are difficult moments along the journey that demand a le…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play